Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
|
|
Sexually Transmitted Diseases Vol. 36; No. 11: P. 686-692 (11..09) - Thursday, November 05, 2009
Yu-Yun Hsu; Susan Jane Fetzer; Keng-Fu Hsu; Yuan-Yuan Chang; Chih-Pyng Huang; Cheng-Yang Chou
At five universities in South Taiwan, a convenience sample of 845 female undergraduate students (ages: 17-36; mean age: 20) was recruited. Demographic information, gynecological history, awareness of HPV and the vaccine, health beliefs, and intention to obtain the vaccination were assessed by self- administered questionnaire.
More than 50 percent of the women were aware of HPV and the vaccine against it. High intention to obtain the vaccine was reported by 63 percent of participants. Demographic factors that predicted HPV vaccination included age, family history of gynecological cancer, personal history of gynecological visit, sexual experience, and awareness of HPV and the vaccine. Health belief factors that predicted vaccination included personal susceptibility of disease, perception of disease severity, attributes of HPV, vaccine cost and availability, and the recommendation of other persons.
"Improving undergraduate women's HPV vaccination rate will require educational campaigns, specifically focused on the efficacy, safety, and benefits of the HPV vaccine and the attributes of HPV infection," the authors concluded. "Targeting incoming students who are not yet sexually active could achieve successful outcomes."
091105
AD091905
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.